The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex several-stage synthetic process. Initial routes focused on peptide fragment coupling, utilizing solid-phase https://saulzywv409636.theobloggers.com/47296064/synthesis-and-study-applications-of-retatrutide